Suppr超能文献

吸入 A 组链球菌制剂气雾剂治疗肺癌的疗效。

The efficacy of the inhalation of an aerosolized Group A streptococcal preparation in the treatment of lung cancer.

机构信息

Department of Cardiothoracic Surgery, The First Affiliated Hospital of Guangzhou Medical College, Guangzhou, China; ; Guangzhou Institute of Respiratory Disease & China State Key Laboratory of Respiratory Disease, Guangzhou, China;

出版信息

Chin J Cancer Res. 2012 Dec;24(4):346-52. doi: 10.3978/j.issn.1000-9604.2012.10.08.

Abstract

OBJECTIVE

To observe the efficacy of the inhalation of an aerosolized group A streptococcal (GAS) preparation in treating orthotopic lung cancer in mouse models and assess the feasibility, safety, and effectiveness of this administration mode for lung cancer.

METHODS

Lewis lung carcinoma (LLC) cell strains were administered via intrathoracic injection to establish orthotopic lung cancer mouse models. After the tumor-bearing models were successfully established, as confirmed by computed tomography, the mice were administered by inhalation with an aerosolized GAS preparation (GAS group) or aerosolized normal saline (control group). The anti-tumor effect of the aerosolized GAS preparation was evaluated histologically; meanwhile, the survival and quality of life were compared between these two groups.

RESULTS

The aerosolized GAS preparation showed remarkably anti-tumor effect, causing the necrosis of the orthotopic lung cancer cells in tumor-bearing mice. Furthermore, mice in the GAS group had significantly better quality of life and longer survival than those in control group.

CONCLUSIONS

The inhalation of aerosolized GAS preparation may be a feasible, safe and effective solution for lung cancer.

摘要

目的

观察雾化 A 组链球菌(GAS)制剂治疗原位肺癌小鼠模型的疗效,并评估该给药方式治疗肺癌的可行性、安全性和有效性。

方法

通过胸腔内注射建立Lewis 肺癌(LLC)细胞株原位肺癌小鼠模型。在通过计算机断层扫描确认肿瘤模型建立成功后,对小鼠进行雾化 GAS 制剂(GAS 组)或雾化生理盐水(对照组)吸入治疗。通过组织学评估雾化 GAS 制剂的抗肿瘤作用,同时比较两组之间的生存和生活质量。

结果

雾化 GAS 制剂显示出显著的抗肿瘤作用,导致荷瘤小鼠原位肺癌细胞坏死。此外,GAS 组的小鼠生活质量明显优于对照组,且生存期更长。

结论

雾化 GAS 制剂吸入可能是治疗肺癌的一种可行、安全且有效的方法。

相似文献

本文引用的文献

2
Cetuximab in non-small-cell lung cancer.西妥昔单抗在非小细胞肺癌中的应用。
Transl Lung Cancer Res. 2012 Mar;1(1):54-60. doi: 10.3978/j.issn.2218-6751.11.01.
8
Active-specific immunotherapy for non-small cell lung cancer.非小细胞肺癌的主动特异性免疫治疗。
J Thorac Dis. 2011 Jun;3(2):105-14. doi: 10.3978/j.issn.2072-1439.2010.12.06.
9
Current status of immunotherapy for the treatment of lung cancer.肺癌免疫治疗的现状。
J Thorac Dis. 2010 Dec;2(4):237-44. doi: 10.3978/j.issn.2072-1439.2010.11.6.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验